PMID- 30445673 OWN - NLM STAT- MEDLINE DCOM- 20190218 LR - 20231004 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 19 IP - 11 DP - 2018 Nov 15 TI - Design of a 3D BMP-2-Delivering Tannylated PCL Scaffold and Its Anti-Oxidant, Anti-Inflammatory, and Osteogenic Effects In Vitro. LID - 10.3390/ijms19113602 [doi] LID - 3602 AB - In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold. The BMP-2/TA/PCL scaffold showed controlled and sustained BMP-2 release. It effectively scavenged reactive oxygen species (ROS) in cells, and increased the proliferation of MC3T3-E1 cells pre-treated with hydrogen peroxide (H(2)O(2)). Additionally, the BMP-2/TA/PCL scaffold significantly suppressed the mRNA levels of pro-inflammatory cytokines, including matrix metalloproteinases-3 (MMP-3), cyclooxygenase-2 (COX-2), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha), in lipopolysaccharide (LPS)-induced MC3T3-E1 cells. Furthermore, it showed outstanding enhancement of the osteogenic activity of MC3T3-E1 cells through increased alkaline phosphatase (ALP) activity and calcium deposition. Our findings demonstrated that the BMP-2/TA/PCL scaffold plays an important role in scavenging ROS, suppressing inflammatory response, and enhancing the osteogenic differentiation of cells. FAU - Lee, Jae Yong AU - Lee JY AD - Department of Orthopedic Surgery and Rare Diseases Institute, Korea University Guro Hospital, Korea University College of Medicine, 148 Guro-dong, Guro-gu, Seoul 08308, Korea. bulegir@nate.com. FAU - Lim, Hyunwoong AU - Lim H AD - Department of Industrial Management Engineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea. limhw@korea.ac.kr. FAU - Ahn, Jae Won AU - Ahn JW AD - Department of Systems Biotechnology, Chung-Ang University, Anseong, Gyeonggi-do 17546, Korea. pinkymonkey1@naver.com. FAU - Jang, Dongsik AU - Jang D AD - Department of Industrial Management Engineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea. Jang@korea.ac.kr. FAU - Lee, Seung Hee AU - Lee SH AD - Department of Nursing, Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Korea. freelovein@hanmail.net. FAU - Park, Kyeongsoon AU - Park K AUID- ORCID: 0000-0003-3625-4128 AD - Department of Systems Biotechnology, Chung-Ang University, Anseong, Gyeonggi-do 17546, Korea. kspark1223@cau.ac.kr. FAU - Kim, Sung Eun AU - Kim SE AD - Department of Orthopedic Surgery and Rare Diseases Institute, Korea University Guro Hospital, Korea University College of Medicine, 148 Guro-dong, Guro-gu, Seoul 08308, Korea. sekim10@korea.ac.kr. LA - eng GR - 2017/Chung-Ang University Research Scholarship Grants/ PT - Journal Article DEP - 20181115 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Antioxidants) RN - 0 (Bone Morphogenetic Protein 2) RN - 0 (Lipopolysaccharides) RN - 0 (Polyesters) RN - 0 (RNA, Messenger) RN - 0 (Reactive Oxygen Species) RN - 0 (Tannins) RN - 24980-41-4 (polycaprolactone) RN - EC 3.1.3.1 (Alkaline Phosphatase) RN - SY7Q814VUP (Calcium) SB - IM MH - Alkaline Phosphatase/metabolism MH - Animals MH - Anti-Inflammatory Agents/*pharmacology MH - Antioxidants/*pharmacology MH - Bone Morphogenetic Protein 2/*pharmacology MH - Calcium/metabolism MH - Cell Line MH - Cell Survival/drug effects MH - Drug Liberation MH - Lipopolysaccharides/pharmacology MH - Mice MH - Osteogenesis/*drug effects MH - Photoelectron Spectroscopy MH - Polyesters/*chemistry MH - RNA, Messenger/genetics/metabolism MH - Reactive Oxygen Species/metabolism MH - Tannins/*chemistry MH - Tissue Scaffolds/*chemistry PMC - PMC6274927 OTO - NOTNLM OT - 3D scaffold OT - anti-inflammation OT - anti-oxidation OT - bone morphogenic protein-2 (BMP-2) OT - osteogenic differentiation OT - polycaprolactone (PCL) OT - tannic acid (TA) COIS- The authors have no conflicts of interest to declare. EDAT- 2018/11/18 06:00 MHDA- 2019/02/20 06:00 PMCR- 2018/11/01 CRDT- 2018/11/18 06:00 PHST- 2018/10/10 00:00 [received] PHST- 2018/11/05 00:00 [revised] PHST- 2018/11/12 00:00 [accepted] PHST- 2018/11/18 06:00 [entrez] PHST- 2018/11/18 06:00 [pubmed] PHST- 2019/02/20 06:00 [medline] PHST- 2018/11/01 00:00 [pmc-release] AID - ijms19113602 [pii] AID - ijms-19-03602 [pii] AID - 10.3390/ijms19113602 [doi] PST - epublish SO - Int J Mol Sci. 2018 Nov 15;19(11):3602. doi: 10.3390/ijms19113602.